全文获取类型
收费全文 | 803篇 |
免费 | 39篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 55篇 |
妇产科学 | 13篇 |
基础医学 | 73篇 |
口腔科学 | 11篇 |
临床医学 | 76篇 |
内科学 | 216篇 |
皮肤病学 | 21篇 |
神经病学 | 6篇 |
特种医学 | 139篇 |
外科学 | 149篇 |
综合类 | 9篇 |
预防医学 | 24篇 |
眼科学 | 4篇 |
药学 | 22篇 |
肿瘤学 | 27篇 |
出版年
2022年 | 5篇 |
2021年 | 21篇 |
2020年 | 2篇 |
2019年 | 9篇 |
2018年 | 19篇 |
2017年 | 8篇 |
2016年 | 11篇 |
2015年 | 18篇 |
2014年 | 21篇 |
2013年 | 29篇 |
2012年 | 23篇 |
2011年 | 19篇 |
2010年 | 32篇 |
2009年 | 24篇 |
2008年 | 19篇 |
2007年 | 14篇 |
2006年 | 21篇 |
2005年 | 13篇 |
2004年 | 16篇 |
2003年 | 19篇 |
2002年 | 11篇 |
2001年 | 19篇 |
2000年 | 9篇 |
1999年 | 13篇 |
1998年 | 39篇 |
1997年 | 49篇 |
1996年 | 46篇 |
1995年 | 36篇 |
1994年 | 21篇 |
1993年 | 22篇 |
1992年 | 13篇 |
1991年 | 15篇 |
1990年 | 14篇 |
1989年 | 24篇 |
1988年 | 29篇 |
1987年 | 24篇 |
1986年 | 24篇 |
1985年 | 13篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 14篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1976年 | 5篇 |
1975年 | 10篇 |
1974年 | 2篇 |
1965年 | 2篇 |
排序方式: 共有847条查询结果,搜索用时 15 毫秒
101.
A. P. Anselmo C. Cartoni A. Pacchiarotti E. Pescarmona A. Cafolla E. Rendina F. Mandelli 《Annals of hematology》1994,68(6):311-313
Summary The authors present the case of a 20-yearold woman who developed a peripheral neuroectodermal neoplasm of the thoracopulmonary region (Askin tumor) 7 years after achieving complete remission of stage-IV Hodgkin's disease. The previous treatment had consisted of eight courses of alternating MOPP/ ABVD combined with involved-field 20-Gy radiotherapy. The second neoplasm appeared in a nonirradiated area of the chest wall, with erosion of the ribs as shown by sonography and computed tomography. The histological pattern was in accordance with a generic diagnosis of a malignant small cell tumor; the immunostaining positivity of the neoplastic cells for the neuron-specific enolase allowed us to make the diagnosis of a tumor with a neuroectodermal origin. Partial resection of the neoplasm and four courses of chemotherapy including adriamycin, cisplatin, and ifosfamide induced a complete remission, confirmed by surgical restaging. She is alive and well 10 months after the completion of therapy. The clinical, radiological, and microscopic features of this tumor occurring as a secondary neoplasm after Hodgkin's disease are described. 相似文献
102.
Winton EF; Srinivasiah J; Kim BK; Hillyer CD; Strobert EA; Orkin JL; Swenson RB; McClure HM; Myers LA; Saral R 《Blood》1994,84(1):65-73
Using a recently developed hepsulfam-induced pancytopenia model in rhesus macaques, we have studied the effects of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on marrow regeneration. Control animals were given hepsulfam (1.5 g/m2 by a single 30-minute intravenous [i.v.] injection, n = 4), while study animals received hepsulfam followed by rhIL-6, rhIL-3, or a combination of rhIL-6 and rhIL-3 (n = 3 per study group). Each cytokine was administered by once- daily subcutaneous (SC) injection (15 micrograms/kg/d) for 3 weeks beginning the day after chemotherapy (days 2 through 22). Mean platelet counts in control animals were < 100,000/microL on days 15 through 24, with 50% of the counts < 50,000/microL and two of four animals requiring platelet transfusion. In the rhIL-6- and rhIL-6/rhIL-3- treated groups, the nadir mean platelet counts were 164,000 +/- 58,700/microL and 162,300 +/- 23,800/microL, respectively, and occurred on day 15. Platelet counts in the rhIL-3-treated group were similar to those in controls. Mean absolute neutrophil counts (ANCs) < 1,000/microL occurred on days 10 through 29 in control animals, days 8 through 15 in rhIL-6-treated animals, and days 6 through 8 and 13 in rhIL-6/rhIL-3-treated animals. The frequency of ANCs < 500/microL was significantly less in the rhIL-6- and rhIL-6/rhIL-3-treated groups versus control groups (2.7 +/- 0.6 and 2.0 +/- 1.0 vs 7.0 +/- 1.4 occurrences, respectively; P < .05). rhIL-3-treated animals had ANCs similar to those in controls; one animal died with septicemia on day 21. Monkeys receiving rhIL-6 were significantly more anemic during the cytokine administration period; however, the anemia resolved by day 24. Coadministration of rhIL-3 and rhIL-6 partially corrected the anemia. The data indicate that rhIL-6 prevents significant thrombocytopenia and shortens the neutropenic period in this chemotherapy model. 相似文献
103.
104.
Bretan PN Jr; Vigneron DB; Hricak H; McClure RD; Yen TS; Moseley M; Tanagho EA; James TL 《Radiology》1987,162(3):867-871
To evaluate the reliability of phosphorus-31 magnetic resonance (MR) spectroscopy in the assessment of acute testicular ischemia, vascular integrity, and spermatogenesis, the authors studied in vivo canine and primate testicles grouped as follows: group 1 testes (n = 8), in situ canine controls; group 2 (n = 11), canine testes subjected to warm ischemia; group 3, canine (n = 4) and primate (n = 4) testicles from hormone-treated animals. Group 1 control testicles showed high monophosphoester (MP) levels; low levels of inorganic phosphate (Pi), phosphodiester (PD), and phosphocreatine; and high levels of adenosine triphosphate (ATP). Group 2 testes revealed a time-dependent decay of MP/Pi ratios (from 2.1 to 0.70). Regeneration of ATP was noted in the acute reperfusion period. After 6 weeks of pituitary gonadotropin suppression, group 3 testes showed a significant decrease (P less than .05) in MP/PD ratios from a control level of 2.6 +/- 0.3 and a decrease in the MP/beta-ATP ratio from 2.4 +/- 0.1 to 1.8 +/- 0.3. P-31 MR spectroscopy appears to be a potential method for noninvasively assessing testicular ischemic injury and the metabolic integrity of spermatogenesis. 相似文献
105.
106.
107.
108.
109.
110.
Giuseppe Mossetti Luigi Gennari Domenico Rendina Gianpaolo De Filippo Daniela Merlotti Vincenzo De Paola Pina Fusco Teresa Esposito Fernando Gianfrancesco Giuseppe Martini Ranuccio Nuti Pasquale Strazzullo 《Calcified tissue international》2008,83(6):414-424
Bisphosphonates are first-choice drugs for treatment of Paget’s disease of bone (PDB); nevertheless, acquired resistance to
bisphosphonate therapy has been described in PDB patients. The 1,25(OH)2D3/vitamin D receptor (VDR) system influences the effectiveness of antiresorptive treatments in metabolic bone disorders. This
study evaluated the relationship between acquired resistance to clodronate treatment and BsmI, TaqI, and FokI VDR polymorphisms in Caucasian patients with polyostotic PDB (n = 84). We also evaluated the influence of mutations in exons 7 and 8 of the sequestosome 1 (SQSTM1) gene on the occurrence of this phenomenon. All patients were treated from diagnosis for several cycles with intravenous clodronate
infusion (1500 mg/cycle). Acquired resistance to clodronate treatment was defined as the failure of total alkaline phosphatase
serum levels to be suppressed to at least 50% of the patient’s previous highest levels during a subsequent treatment course
with the same compound, which produced a >50% response after the first exposure. During an observation period of 10.6 ± 2.7 years,
31 PDB patients (36.9%) showed acquired resistance to clodronate. It was observed that the bb and TT
VDR genotypes as well as a lower persistence of the biochemical response to the first treatment course were significantly and
independently associated with the risk of developing resistance to clodronate treatment. SQSTM1 gene mutations, considered altogether, did not influence the occurrence of this phenomenon. Our results indicate that 3′VDR allelic variants and duration of biochemical response to the first treatment course are independent predictors of acquired
resistance to clodronate treatment in patients with polyostotic PDB. 相似文献